Differences in immunological profile in atopic dermatitis patients with and without dupilumab therapy
Our aim is to determine the number of leukocytes, T lymphocytes and B lymphocytes and the expression of activation markers CD200 and CD23 on B lymphocytes in atopic dermatitis (AD) patients (treated and not treated with dupilumab) during the pollen season. We examined 29 patients not treated with du...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-08-01
|
Series: | Immunological Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/25785826.2024.2387882 |